Safety and Efficacy of Checkpoint Inhibition in Patients With Melanoma and Preexisting Autoimmune Disease
Ann Intern Med
.
2021 Sep;174(9):1345-1346.
doi: 10.7326/L21-0442.
Authors
Monique K van der Kooij
1
,
Karijn P M Suijkerbuijk
2
,
Olaf M Dekkers
1
,
Ellen Kapiteijn
1
Affiliations
1
Leiden University Medical Center, Leiden, the Netherlands.
2
University Medical Center Utrecht, Utrecht, the Netherlands.
PMID:
34543594
DOI:
10.7326/L21-0442
No abstract available
Publication types
Letter
Comment
MeSH terms
Autoimmune Diseases* / complications
Autoimmune Diseases* / drug therapy
Humans
Melanoma* / drug therapy